Correlation Between 4D Molecular and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Mersana Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Mersana Therapeutics.
Diversification Opportunities for 4D Molecular and Mersana Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between FDMT and Mersana is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between 4D Molecular and Mersana Therapeutics
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 2.29 times less risky than Mersana Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 182.00 in Mersana Therapeutics on September 2, 2024 and sell it today you would earn a total of 46.00 from holding Mersana Therapeutics or generate 25.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Mersana Therapeutics
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Mersana Therapeutics |
4D Molecular and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Mersana Therapeutics
The main advantage of trading using opposite 4D Molecular and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |